Ketamine Therapy for Depression: What It Costs and Who Qualifies
Ketamine has been used as an anesthetic for decades, but its role in treating depression — particularly severe, treatment-resistant cases — has attracted serious attention from psychiatrists and researchers. If you're exploring this option, here's what you need to understand about how it works, what it typically costs, and what determines who is a good candidate.
What Is Ketamine Therapy for Depression?
Ketamine is a dissociative anesthetic that, at lower doses, produces rapid antidepressant effects in some people. Unlike traditional antidepressants that can take weeks to work, ketamine's effects can appear within hours or days. This speed is one of the key reasons it's being used for people who haven't responded to other treatments — including those experiencing suicidal ideation.
There are two primary forms used in mental health treatment:
| Form | Name | How It's Given | FDA Status |
|---|---|---|---|
| IV ketamine | Racemic ketamine | Intravenous infusion | Off-label use |
| Nasal spray | Esketamine (Spravato) | Self-administered in-clinic | FDA-approved for treatment-resistant depression and MDD with suicidal ideation |
IV ketamine is the older, more widely studied form. Because it's used off-label for depression (meaning outside its original FDA approval), insurance coverage is rare and inconsistent.
Esketamine (Spravato) received FDA approval specifically for depression, which opens more doors for insurance coverage — though coverage still varies significantly by plan.
How the Treatment Actually Works
A typical ketamine infusion course isn't a single session. Most providers structure treatment as a series of infusions over several weeks — commonly six sessions delivered over two to three weeks — followed by maintenance sessions as needed.
Each IV infusion session typically lasts 40 to 60 minutes, during which you remain in a monitored clinical setting. Esketamine sessions involve self-administering the nasal spray under clinical supervision, followed by a monitoring period.
🧠 The exact mechanism isn't fully understood, but ketamine is believed to act on NMDA receptors in the brain, triggering changes in glutamate signaling. This is a fundamentally different pathway than SSRIs and SNRIs, which is why it can work for people who haven't responded to those medications.
What Does Ketamine Therapy Cost?
This is where the landscape varies considerably. Several factors shape the cost:
- Treatment form: IV infusions and esketamine have different cost structures
- Number of sessions: Initial series plus any ongoing maintenance
- Geographic location: Clinic pricing varies significantly by region
- Insurance coverage: The single biggest variable for most patients
- Clinic type: Academic medical centers, private ketamine clinics, and integrated psychiatric practices all price differently
IV ketamine infusions are typically priced per session, and a full initial course can run into thousands of dollars out of pocket. Because this use is off-label, most commercial insurance plans don't cover it — though some patients have had partial success with appeals or medical necessity documentation.
Esketamine (Spravato) has a better insurance coverage picture because of its FDA approval. However, even with coverage, copays, deductibles, and prior authorization requirements mean the out-of-pocket cost varies widely. The drug manufacturer has offered patient assistance programs, though eligibility criteria apply.
💡 The honest answer on cost: without knowing your specific insurance situation, location, and treatment plan, no one can give you a reliable number. Getting a benefits verification and cost estimate from the clinic before starting is essential.
Who Is a Candidate for Ketamine Therapy?
Ketamine isn't a first-line treatment for depression. It's generally considered when other approaches haven't worked. The profile of someone typically considered a candidate includes:
Primary Indicators
- Treatment-resistant depression (TRD): Usually defined as having failed to respond adequately to two or more antidepressant treatments
- Major depressive disorder (MDD): Particularly severe episodes
- Active suicidal ideation: Esketamine has specific FDA approval here due to its rapid onset
- Bipolar depression: Sometimes used, though this requires careful psychiatric evaluation
What Providers Typically Evaluate
Before approving ketamine treatment, a qualified provider will assess:
- Medical history: Ketamine is not appropriate for everyone — certain cardiovascular conditions, a history of psychosis or schizophrenia, active substance use disorders, or uncontrolled hypertension may be disqualifying factors
- Current medications: Some interactions require adjustment
- Prior treatment history: Documentation of previous medication trials is usually required for insurance purposes and clinical appropriateness
- Psychiatric diagnosis: Confirmed by a licensed mental health professional
Who May Not Be a Good Fit
People with a history of certain conditions — particularly psychotic disorders, active substance use, or specific heart conditions — may not be appropriate candidates. This determination is always made by a qualified clinician based on individual medical history.
What to Ask Before Pursuing Ketamine Therapy
If you're considering this treatment, these are the questions worth bringing to a provider conversation:
- What form of ketamine do you offer, and why? (IV versus esketamine)
- What does the full treatment protocol look like, including maintenance sessions?
- What is your experience with patients with my specific diagnosis and history?
- Will you coordinate with my existing psychiatrist or therapist?
- What does your clinic's cost structure look like, and do you assist with insurance verification?
- What happens if the treatment doesn't work? What's the follow-up plan?
The Role of Therapy Alongside Ketamine
Many clinicians emphasize that ketamine works best as part of a broader treatment plan — not as a standalone fix. The window of neuroplasticity that ketamine may open is often cited as an opportunity to engage more effectively in psychotherapy. Some ketamine clinics integrate psychotherapy into their programs; others are purely medical infusion centers. That distinction matters if you're evaluating providers.
What "Treatment-Resistant" Actually Means
The term gets used loosely, but in clinical practice it typically means a patient has tried an adequate dose of an antidepressant for an adequate period — generally at least four to eight weeks — and hasn't seen sufficient improvement. Most definitions require failure of at least two different medication trials. If you're uncertain whether your history qualifies you as treatment-resistant, a psychiatrist who specializes in mood disorders is the right person to make that assessment.
🔍 The bottom line: ketamine therapy represents a genuinely promising option for people with difficult-to-treat depression, but it's not the right fit for everyone, the costs are significant and variable, and the decision requires careful evaluation by qualified medical professionals who know your full history.
